期刊文献+

Toll样受体相关疾病研究进展 被引量:5

Research Progress of Toll-like Receptor Related Diseases
下载PDF
导出
摘要 Toll样受体(Toll-like receptors, TLRs)家族存在于所有活的多细胞生物中。研究表明,TLRs在对机体天然免疫、识别病原体方面包括感染性、自身免疫性、过敏性、炎症和癌症在内的多种疾病的发病机制中发挥了非常重要的作用。简要介绍了TLRs家族受体相关的常见疾病,结合已有的成果对相关疾病相关受体的研究方法及应用现状进行阐述。最后,对Toll样受体为人类克服相关疾病的未来发展方向进行展望。 Toll-like receptors family exists in all living multicellular organisms. Studies have shown that they play very important role in the pathogenesis of a variety of diseases, including infectious, autoimmune, allergic, inflammatory and cancer. Common diseases related to TLRs family receptors were briefly introduced. The research methods and application status of related receptors of related diseases were described in combination with the existing achievements. Finally, the future development direction of Toll-like receptor in overcoming related diseases was looked forward.
作者 杨宏鹏 张首国 曹莹 彭涛 温晓雪 王林 胡利明 YANG Hong-peng;ZHANG Shou-guo;CAO Ying;PENG Tao;WEN Xiao-xue;WANG Lin;HU Li-ming(Faculty of Environment&Life,Beijing University of Technology,Beijing 100124,China;Institute of Radiation Medicine,Academy of Military Medical Sciences,Beijing 100850,China;College of Pharmacy,Anhui Medical University,Hefei 230032,China)
出处 《科学技术与工程》 北大核心 2022年第35期15427-15435,共9页 Science Technology and Engineering
基金 国家自然科学基金(21102176,21272273)。
关键词 TOLL样受体 疾病 研究方法 应用现状 Toll-like receptors diseases research methods application status
  • 相关文献

参考文献7

二级参考文献84

  • 1范莹,金英,闫恩志,杨菁,宗志红,齐志敏.布洛芬对淀粉样β蛋白片段1~40引起的大鼠海马p38 MAP激酶信号传导通路及半胱氨酸天冬氨酸蛋白酶级联的影响(英文)[J].中国药理学与毒理学杂志,2007,21(2):81-89. 被引量:3
  • 2Wang XH, Smith C, Yin H. Targeting Toll-like receptors with small molecule agents [J]. Chem Soc Rev, 2013, 42 ( 12 ) : 4859-4866.
  • 3Takeda K, Akira S. TLR signaling pathways [J]. Seminars in Immunology, 2004, 16 (1) : 3-9.
  • 4Roach JC, Glusman G, Rowen L, et al. The evolution of ver- tebrate Toll-like receptors [J]. Proc Natl Acad Sci, 2005, 102 (27) : 9577-9582.
  • 5Cheng K, Wang XH, Zhang ST, et al. Discovery of small- molecule inhibitors of the TLR1/TLR2 complex [J]. Angew ChemIntEd, 2012, 51 (49) : 12246-12249.
  • 6Tsolmongyn B, Koide N, Jambalganiin U, et al. A Toll-like receptor 2 ligand, Pam3CSK4, augments interferon-y-induced nitric oxide production via a physical association between MyD88 and interferon-7-receptor in vascular endothelial cells [J]. J Immunol, 2013, 140 (3) : 352-361.
  • 7Lombardi V, Van Overtvelt L, Horiot S. Toll-like receptor 2 agonist Pam3CSK4 enhances the induction of antigenspecific to- lerance via the sublingual route [J]. Clin Exp Allergy, 2008, 38 (11) : 1819-1829.
  • 8Zhang Y, Luo FF, Cai YC. TLR1/TLR2 agonist induces tumor regression by reciprocal modulation of effector and regulatory T cells[J].JImmunol, 2011, 186 (4) : 1963-1969.
  • 9Sugiyama T, Hoshino K, Saito M, et al. Immuno adjuvant effects of polyadenylic polyuridylic acids through TLR3 and TLR7 [J]. Int Immunol, 2008, 20 ( 1 ) : 1-9.
  • 10Hennessy E J, Parker AE, O' Neill LA, et al. Targeting Toll-like receptors emerging therapeutics? [J]. Nat Rev Immu- nol, 2010, 9 (4) : 293-307.

共引文献591

同被引文献48

引证文献5

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部